BioCentury
ARTICLE | Clinical News

VX-509: Additional Phase IIb data

February 17, 2014 8:00 AM UTC

Additional data from a double-blind, international Phase IIb trial in 358 patients with active RA who had an inadequate response to methotrexate showed that all 4 doses of VX-509 plus methotrexate fo...